GLI1 and esophageal squamous cell carcinoma: Importantly, stromal CCL22 was related to intratumoral Gli1 in clinical ESCC samples, suggesting that the combined treatment that targeted FAK and HH pathways is efficient in treating ESCC, especially in the context of TME (Figure 7).